Management of Microproteinuria vs Proteinuria
Introduction to Management
- The American Journal of Kidney Diseases recommends that both microalbuminuria and macroalbuminuria/proteinuria require ACE inhibitor or ARB therapy uptitrated to maximum tolerated dose as first-line treatment, combined with aggressive blood pressure control targeting systolic BP <120 mmHg and strict dietary sodium restriction to <2.0 g/day 1, 2, 3
Definitions and Diagnostic Confirmation
- Microalbuminuria is defined as 30-300 mg albumin/g creatinine on spot urine testing, and requires confirmation with 2 of 3 positive measurements to establish persistence, according to the American Journal of Kidney Diseases 4, 5, 6
- Macroalbuminuria/Proteinuria is defined as >300 mg albumin/g creatinine, and at very high levels (>500-1000 mg/g), total protein measurement is acceptable instead of albumin, as stated by the American Journal of Kidney Diseases 4, 5, 6
First-Line Pharmacologic Management
- The Kidney International guidelines suggest initiating ACE inhibitor or ARB and uptitrating to maximum tolerated dose, not merely the dose that achieves BP control, for both microalbuminuria and proteinuria 1, 2, 3, 7
- For losartan specifically, uptitrate to 100 mg daily for optimal antiproteinuric effect (approximately 30% reduction in proteinuria), as recommended by Praxis Medical Insights 2
Blood Pressure Targets
- For microalbuminuria, target systolic BP <120-130 mmHg using standardized office measurements, according to Kidney International 1, 2, 3
- For proteinuria >1 g/day, target systolic BP <120 mmHg (more aggressive target), as suggested by Kidney International and Praxis Medical Insights 1, 2, 7
Dietary Sodium Restriction
- Restrict dietary sodium to <2.0 g/day (<90 mmol/day) in all patients, as recommended by Kidney International and Praxis Medical Insights 1, 2, 3, 7
- Sodium restriction is synergistic with ACE inhibitor/ARB therapy and enhances antiproteinuric effects, according to Praxis Medical Insights 2, 3
Monitoring Strategy
- For microalbuminuria, retest within 6 months after initiating treatment to assess response, and if significant reduction achieved, continue annual testing, as stated by the American Journal of Kidney Diseases 4, 5, 6
- For proteinuria, check labs every 2-4 weeks initially: serum creatinine, eGFR, potassium, and urine protein-to-creatinine ratio, according to Praxis Medical Insights 2, 7
Management of Treatment-Resistant Proteinuria
- If proteinuria persists despite maximized ACE inhibitor/ARB, add mineralocorticoid receptor antagonist (spironolactone 25-50 mg daily or eplerenone) with careful potassium monitoring, as recommended by Kidney International and Praxis Medical Insights 1, 3, 7
Additional Lifestyle Modifications
- Normalize weight, as recommended by the American Journal of Kidney Diseases and Praxis Medical Insights 4, 5, 3
- Stop smoking, according to Kidney International and Praxis Medical Insights 1, 3
- Exercise regularly, as suggested by Kidney International and Praxis Medical Insights 1, 3